HK1100745A1 - Use of parasitic biological agents from for prevention and control of inflammatory bowel disease - Google Patents

Use of parasitic biological agents from for prevention and control of inflammatory bowel disease

Info

Publication number
HK1100745A1
HK1100745A1 HK07108459.0A HK07108459A HK1100745A1 HK 1100745 A1 HK1100745 A1 HK 1100745A1 HK 07108459 A HK07108459 A HK 07108459A HK 1100745 A1 HK1100745 A1 HK 1100745A1
Authority
HK
Hong Kong
Prior art keywords
immune response
prevention
excessive immune
control
inflammatory bowel
Prior art date
Application number
HK07108459.0A
Other languages
English (en)
Inventor
Joel Weinstock
David E Elliott
Original Assignee
Univ Iowa Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Iowa Res Found filed Critical Univ Iowa Res Found
Publication of HK1100745A1 publication Critical patent/HK1100745A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07108459.0A 1997-12-31 2007-08-03 Use of parasitic biological agents from for prevention and control of inflammatory bowel disease HK1100745A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7014797P 1997-12-31 1997-12-31

Publications (1)

Publication Number Publication Date
HK1100745A1 true HK1100745A1 (en) 2007-09-28

Family

ID=22093437

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07108459.0A HK1100745A1 (en) 1997-12-31 2007-08-03 Use of parasitic biological agents from for prevention and control of inflammatory bowel disease

Country Status (10)

Country Link
US (3) US6764838B2 (ja)
EP (3) EP1041994A4 (ja)
JP (3) JP4733830B2 (ja)
AU (1) AU740776B2 (ja)
CA (1) CA2315790C (ja)
DK (1) DK1749534T3 (ja)
ES (1) ES2430394T3 (ja)
HK (1) HK1100745A1 (ja)
PT (1) PT1749534E (ja)
WO (1) WO1999033479A1 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2315790C (en) * 1997-12-31 2015-10-06 University Of Iowa Research Foundation Use of parasitic biological agents for prevention and control of autoimmune diseases
GB9824034D0 (en) * 1998-11-03 1998-12-30 Univ Nottingham Immunomodulatory factors forimmunosuppressant and antiallergic treatment
US20050118655A1 (en) * 2003-11-17 2005-06-02 University Of Iowa Research Foundation Use of parasitic biological agents for diseases prevention and control
US20060024333A1 (en) * 2004-07-26 2006-02-02 O'connor Daniel J Use of parasitic biological agents for prevention and control of allergic and other IgE-mediated disorders
JP5689585B2 (ja) * 2005-12-30 2015-03-25 パラサイト テクノロジーズ エーエスＰａｒａｓｉｔｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ａ／Ｓ 寄生虫卵を含む組成物および寄生虫卵を分離および保存する方法
DE102006023906A1 (de) * 2006-05-19 2007-11-22 Ovamed Gmbh Verfahren zum Nachweis der Viabilität
US20090202517A1 (en) * 2006-08-17 2009-08-13 Hiroyuki Yoneyama Agents for improving inflammatory bowel disease
GB2447884B (en) * 2007-03-02 2011-10-26 Mark Barnett Treatment for skin disease
EP1977643A1 (de) * 2007-04-02 2008-10-08 Dr. Falk Pharma Gmbh Herstellung einer viablen, lagerfähigen Wurmeiersuspension
US20100260861A1 (en) * 2007-04-10 2010-10-14 Joel Weinstock Treatments with helminths
EP2123774A1 (de) 2008-05-21 2009-11-25 Dr. Falk Pharma Gmbh Verfahren zur Charakterisierung der biologischen Aktivität von Helminth-Eiern
US20100124574A1 (en) * 2008-06-19 2010-05-20 Parasite Technologies A/S Composition Comprising Parasite Eggs And Methods For Isolation And Storage Of Parasite Eggs
JP5935200B2 (ja) * 2010-10-27 2016-06-15 国立大学法人山口大学 蠕虫性寄生生物由来の免疫賦活剤
WO2012137899A1 (ja) * 2011-04-06 2012-10-11 学校法人麻布獣医学園 2型糖尿病の発症を抑制する寄生虫
RU2486238C1 (ru) * 2011-12-29 2013-06-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО СибГМУ Минздравсоцразвития России) СПОСОБ НАГРУЗКИ ДЕНДРИТНЫХ КЛЕТОК АНТИГЕНОМ ИНФЕКЦИОННОГО ПРОИСХОЖДЕНИЯ Opisthorchis felineus
US9224200B2 (en) 2012-04-27 2015-12-29 Parasite Technologies A/S Computer vision based method for extracting features relating to the developmental stages of Trichuris spp. eggs
WO2014151648A1 (en) * 2013-03-15 2014-09-25 Coronado Biosciences, Inc. Treatment of autoimmune disease using helminthic parasites
GB201402909D0 (en) * 2014-02-19 2014-04-02 Univ Southampton Treating infection
US9603875B1 (en) 2016-01-07 2017-03-28 NeuOva, LLC Method of making a consumable product with purified embryonated Trichuris suis ova
FR3069163B1 (fr) * 2017-07-21 2020-07-10 Fondation Mediterranee Infection Extrait aqueux d'un broyat de planaires
EP3801579A1 (en) * 2018-06-04 2021-04-14 Aarhus Universitet Worm products and methods of use
KR102270850B1 (ko) * 2019-11-25 2021-06-28 전남대학교산학협력단 관절염 예방 또는 치료용 약학 조성물
KR102643035B1 (ko) * 2021-05-24 2024-02-29 전남대학교산학협력단 관절염 예방 또는 치료용 약학 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158049A (en) * 1976-09-27 1979-06-12 Edna Mcconnell Clark Foundation Antigen fraction of Schistosoma mansoni eggs suitable for testing for schistosomiasis
US4314992A (en) * 1978-11-08 1982-02-09 Bitakaramire Peter K Process for producing fascioliasis vaccine
US4396600A (en) * 1980-12-18 1983-08-02 Gus Gallucci Adult schistosome worm-derived antigenic substance and method of obtaining same
WO1996040717A1 (en) * 1995-06-07 1996-12-19 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands of cytokines
JP2700088B2 (ja) * 1991-07-25 1998-01-19 房則 濱島 免疫抑制剤
DE69331018T2 (de) * 1992-05-11 2002-06-13 Corvas International, Inc. Neutrophilen inhibitoren aus nematoden
WO1995024425A1 (en) * 1994-03-11 1995-09-14 Board Of Regents, The University Of Texas System Immunomodulatory trichinella substances
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
AU5344996A (en) * 1995-03-23 1996-10-08 Governors Of Dalhousie College And University A process of prolonging organ allograft survival
US5882943A (en) * 1996-07-31 1999-03-16 Aldeen; William Erick Filtration apparatus, kit and method for processing parasite samples
CA2315790C (en) * 1997-12-31 2015-10-06 University Of Iowa Research Foundation Use of parasitic biological agents for prevention and control of autoimmune diseases
GB9824034D0 (en) * 1998-11-03 1998-12-30 Univ Nottingham Immunomodulatory factors forimmunosuppressant and antiallergic treatment
DE10109844A1 (de) * 2001-03-01 2003-02-27 Forschungszentrum Borstel Zent Immunmodulierende Wirkstoffe aus parasitären Würmern und Verfahren zu deren Isolierung
JP2003132677A (ja) * 2001-10-29 2003-05-09 Mitsubishi Electric Corp 半導体記憶装置
US20050118655A1 (en) * 2003-11-17 2005-06-02 University Of Iowa Research Foundation Use of parasitic biological agents for diseases prevention and control
US20060024333A1 (en) * 2004-07-26 2006-02-02 O'connor Daniel J Use of parasitic biological agents for prevention and control of allergic and other IgE-mediated disorders
JP5689585B2 (ja) * 2005-12-30 2015-03-25 パラサイト テクノロジーズ エーエスＰａｒａｓｉｔｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ａ／Ｓ 寄生虫卵を含む組成物および寄生虫卵を分離および保存する方法
US20100124574A1 (en) * 2008-06-19 2010-05-20 Parasite Technologies A/S Composition Comprising Parasite Eggs And Methods For Isolation And Storage Of Parasite Eggs

Also Published As

Publication number Publication date
US7250173B2 (en) 2007-07-31
EP1041994A1 (en) 2000-10-11
JP4733830B2 (ja) 2011-07-27
US6764838B2 (en) 2004-07-20
EP1749534A2 (en) 2007-02-07
US20070298011A1 (en) 2007-12-27
ES2430394T3 (es) 2013-11-20
EP1749534A3 (en) 2007-02-21
US20040202671A1 (en) 2004-10-14
CA2315790C (en) 2015-10-06
EP1749534B1 (en) 2013-08-21
EP1041994A4 (en) 2003-02-19
JP2011016840A (ja) 2011-01-27
WO1999033479A1 (en) 1999-07-08
EP2255820A1 (en) 2010-12-01
JP2014129390A (ja) 2014-07-10
PT1749534E (pt) 2013-09-13
AU1821399A (en) 1999-07-19
DK1749534T3 (da) 2013-09-02
JP2001527048A (ja) 2001-12-25
CA2315790A1 (en) 1999-07-08
US20030039666A1 (en) 2003-02-27
US7833537B2 (en) 2010-11-16
AU740776B2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
HK1100745A1 (en) Use of parasitic biological agents from for prevention and control of inflammatory bowel disease
WO2003045228A3 (en) Methods for treating autoimmune disorders, and reagents related thereto
MY131443A (en) Compounds useful as hypoglycemic agents and for treating alzheimer's disease.
BE2018C038I2 (ja)
IL221381A (en) 4,2-pyrimidindiamine compounds, their use and processes for their preparation
ATE510562T1 (de) Anti-ailim antikörper zur behandlung von crohn's
EP0718285A3 (ja)
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
CA2232001A1 (en) Methods and compositions for prevention and treatment of clostridium difficile-associated diseases
EP0665749A4 (en) METHOD AND COMPOSITION FOR TREATING PARKINSON'S DISEASE.
HK1009641A1 (en) Rapamycin for the treatment of crohn's disease ulcerative colitis or ulcerative proctitis
ATE179330T1 (de) Verbesserte alpha-interferon-zusammensetzung und verfahren zu ihrer herstellung aus leukocyten des menschlichen peripheren blute
Bear et al. Increased autonomic responses to neutral and emotional stimuli in patients with temporal lobe epilepsy.
BG99054A (en) Mycobacterium vaccae for the treatment of continuous autoimmune conditions
WO2008086452A3 (en) Treatment and prevention of alzheimer's disease
MXPA04003773A (es) Uso de leptina para tratar lipoatrofia humana y metodo para determinar la predisposicion a dicho tratamiento.
EP0988316A4 (en) DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO IRON OVERLOAD AND FERRITIVE CONDITIONS, METHODS AND COMPOSITIONS THEREOF
IL117295A (en) 4-Aminotetrahydro-benzisoxazole or-isothiazole compounds and pharmaceutical compositions comprising them
WO2003097082A3 (en) Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
IL158060A0 (en) Use of cd25 binding molecules in steroid-resistant patients
DE68924316D1 (de) Menschliches Gamma-Interferon, Verfahren zu seiner Herstellung und seine Verwendung.
IL124729A0 (en) Compositions containing bismuth for the prevention and treatment of gastrointestinal disorders
MX9804577A (es) Composiciones que contienen bismuto y uno o mas antimicrobianos, para la prevencion y tratamiento de trastornos gastrointestinales.
AU2003224453A1 (en) Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h-(1,2,4)-triazole for the treatment of autoimmune diseases
WO1998036758A3 (de) Sauerstoffanionradikale enthaltende therapeutische mittel und deren verwendung zur behandlung von morbus parkinson

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161211